Royal Bank of Canada’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
74,101
+627
| +0.9% | +$12.9K | ﹤0.01% | 3239 |
|
|
2025
Q1 | $1.51M | Sell |
73,474
-542
| -0.7% | -$11.1K | ﹤0.01% | 2870 |
|
|
2024
Q4 | $1.68M | Buy |
74,016
+4,722
| +7% | +$107K | ﹤0.01% | 2757 |
|
|
2024
Q3 | $1.71M | Sell |
69,294
-2,918
| -4% | -$71.8K | ﹤0.01% | 2755 |
|
|
2024
Q2 | $1.67M | Sell |
72,212
-874
| -1% | -$20.2K | ﹤0.01% | 2732 |
|
|
2024
Q1 | $1.76M | Sell |
73,086
-622
| -0.8% | -$15K | ﹤0.01% | 2689 |
|
|
2023
Q4 | $1.7M | Buy |
73,708
+3,789
| +5% | +$87.2K | ﹤0.01% | 2754 |
|
|
2023
Q3 | $1.42M | Buy |
69,919
+5,950
| +9% | +$121K | ﹤0.01% | 2728 |
|
|
2023
Q2 | $1.49M | Buy |
63,969
+3,574
| +6% | +$83.5K | ﹤0.01% | 2706 |
|
|
2023
Q1 | $1.41M | Buy |
60,395
+1,156
| +2% | +$26.9K | ﹤0.01% | 2764 |
|
|
2022
Q4 | $1.49M | Sell |
59,239
-3,111
| -5% | -$78.4K | ﹤0.01% | 2775 |
|
|
2022
Q3 | $1.65M | Sell |
62,350
-3,465
| -5% | -$91.5K | ﹤0.01% | 2630 |
|
|
2022
Q2 | $1.9M | Sell |
65,815
-27,841
| -30% | -$805K | ﹤0.01% | 2583 |
|
|
2022
Q1 | $3.23M | Buy |
93,656
+13,263
| +16% | +$457K | ﹤0.01% | 2275 |
|
|
2021
Q4 | $3.52M | Buy |
80,393
+29,557
| +58% | +$1.29M | ﹤0.01% | 2268 |
|
|
2021
Q3 | $2.58M | Sell |
50,836
-49,655
| -49% | -$2.52M | ﹤0.01% | 2483 |
|
|
2021
Q2 | $5.23M | Buy |
100,491
+7,589
| +8% | +$395K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $4.25M | Buy |
92,902
+24,170
| +35% | +$1.1M | ﹤0.01% | 2079 |
|
|
2020
Q4 | $3.16M | Sell |
68,732
-15,679
| -19% | -$720K | ﹤0.01% | 2189 |
|
|
2020
Q3 | $3.29M | Buy |
84,411
+14,435
| +21% | +$562K | ﹤0.01% | 1995 |
|
|
2020
Q2 | $2.66M | Buy |
69,976
+27,336
| +64% | +$1.04M | ﹤0.01% | 2100 |
|
|
2020
Q1 | $1.15M | Buy |
+42,640
| New | +$1.15M | ﹤0.01% | 2548 |
|